D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
BSX holding history
Boston Scientific Corp in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
BSX overviewAll 13F holders of BSXFull Q2 2026 holdings
- Shares (Q2 2026)
- 25,457,409
- Value
- $1.09B
- % of portfolio
- 0.7%
- Quarters held
- 22
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 25,457,409 | $1.09B | 0.7% | +1,145,057+4.7% | Added | Holders |
| Q1 2026 | 24,312,352 | $1.53B | 1.2% | +13,063,148+116.1% | Added | Holders |
| Q4 2025 | 11,249,204 | $1.07B | 0.8% | +2,338,849+26.2% | Added | Holders |
| Q3 2025 | 8,910,355 | $869.9M | 0.7% | +2,155,204+31.9% | Added | Holders |
| Q2 2025 | 6,755,151 | $725.6M | 0.7% | +2,916,007+76.0% | Added | Holders |
| Q1 2025 | 3,839,144 | $387.3M | 0.5% | +3,075,641+402.8% | Added | Holders |
| Q4 2024 | 763,503 | $68.2M | 0.1% | −992,596−56.5% | Reduced | Holders |
| Q3 2024 | 1,756,099 | $147.2M | 0.2% | +937,465+114.5% | Added | Holders |
| Q2 2024 | 818,634 | $63.0M | 0.1% | −580,159−41.5% | Reduced | Holders |
| Q1 2024 | 1,398,793 | $95.8M | 0.1% | +879,341+169.3% | Added | Holders |
| Q4 2023 | 519,452 | $30.0M | <0.1% | −618,105−54.3% | Reduced | Holders |
| Q3 2023 | 1,137,557 | $60.1M | 0.1% | −28,268−2.4% | Reduced | Holders |
| Q2 2023 | 1,165,825 | $63.1M | 0.1% | +694,070+147.1% | Added | Holders |
| Q1 2023 | 471,755 | $23.6M | <0.1% | −355,371−43.0% | Reduced | Holders |
| Q4 2022 | 827,126 | $38.3M | 0.1% | −994,886−54.6% | Reduced | Holders |
| Q3 2022 | 1,822,012 | $70.6M | 0.1% | −854,832−31.9% | Reduced | Holders |
| Q2 2022 | 2,676,844 | $99.8M | 0.2% | +2,092,621+358.2% | Added | Holders |
| Q1 2022 | 584,223 | $25.9M | <0.1% | −872,392−59.9% | Reduced | Holders |
| Q4 2021 | 1,456,615 | $61.9M | 0.1% | +1,138,662+358.1% | Added | Holders |
| Q3 2021 | 317,953 | $13.8M | <0.1% | +217,113+215.3% | Added | Holders |
| Q2 2021 | 100,840 | $4.31M | <0.1% | −1,640,904−94.2% | Reduced | Holders |
| Q1 2021 | 1,741,744 | $67.3M | 0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.